American vaccine maker Novavax has pushed back the start of a late-stage trial for its experimental Covid-19 inoculation in the US, and said on Monday it may begin the tests “in the coming weeks.”
“Novavax expects its pivotal Phase 3 clinical trial in the US and Mexico to begin in the coming weeks,” the company said in a statement, adding that more than 100 trial sites have been selected.
Continue reading https://on.rt.com/aw5l